Amy Davidoff

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. doi Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 47:1229-36. 2009
  2. doi Use and spending on antineoplastic therapy for Medicare beneficiaries with cancer
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Med Care 51:351-60. 2013
  3. doi Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Cancer 119:1257-65. 2013
  4. doi Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer
    Amy J Davidoff
    University of Maryland Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
    J Thorac Oncol 6:934-41. 2011
  5. ncbi Effects of managed care on service use and access for publicly insured children with chronic health conditions
    Amy Davidoff
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Pediatrics 119:956-64. 2007
  6. pmc Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Haematologica 97:128-32. 2012
  7. doi Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland Baltimore, 220 Arch St, 12th Floor, Room 214, Baltimore, MD 21201, USA
    J Clin Oncol 28:2191-7. 2010
  8. doi Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, USA
    Health Aff (Millwood) 29:1255-63. 2010
  9. pmc How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction
    Bruce Stuart
    Department of Pharmaceutical Health Services Research, Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore, Baltimore, MD
    Health Serv Res 48:1960-77. 2013
  10. doi Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer
    Ilene H Zuckerman
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    J Am Geriatr Soc 57:1403-10. 2009

Detail Information

Publications20

  1. doi Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 47:1229-36. 2009
    ..Recent healthcare system and environmental changes may have reduced treatment gaps...
  2. doi Use and spending on antineoplastic therapy for Medicare beneficiaries with cancer
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Med Care 51:351-60. 2013
    ..Oral antineoplastic drugs, not generally covered by Medicare Part B, have assumed an increasingly important role in cancer treatment...
  3. doi Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Cancer 119:1257-65. 2013
    ..In the current study, the authors examined out-of-pocket (OOP) spending and burden relative to income for Medicare beneficiaries with cancer...
  4. doi Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer
    Amy J Davidoff
    University of Maryland Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
    J Thorac Oncol 6:934-41. 2011
    ..Combined modality therapy (CMT; radiation and chemotherapy) is indicated for fit, elderly patients with inoperable, locally advanced non-small cell lung cancer. We used population level data to examine effects of CMT on survival...
  5. ncbi Effects of managed care on service use and access for publicly insured children with chronic health conditions
    Amy Davidoff
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Pediatrics 119:956-64. 2007
    ..Our goal was to estimate the effects of managed care program type on service use and access for publicly insured children with chronic health conditions...
  6. pmc Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Haematologica 97:128-32. 2012
    ..Specialist access, financial resources and mobility are key determinants of receipt of erythropoiesis-stimulating agents among myelodysplastic syndrome patients...
  7. doi Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland Baltimore, 220 Arch St, 12th Floor, Room 214, Baltimore, MD 21201, USA
    J Clin Oncol 28:2191-7. 2010
    ..This study extends recent population-based analyses focusing on treatment and survival benefit from use of platinum-doublet therapy, and addressing the role of performance status (PS)...
  8. doi Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, USA
    Health Aff (Millwood) 29:1255-63. 2010
    ..Our findings emphasize the need to expand eligibility and improve policies to foster enrollment...
  9. pmc How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction
    Bruce Stuart
    Department of Pharmaceutical Health Services Research, Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore, Baltimore, MD
    Health Serv Res 48:1960-77. 2013
    ..Assess impact of Medicare Part D benefit phases on adherence with evidence-based medications after hospitalization for an acute myocardial infarction...
  10. doi Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer
    Ilene H Zuckerman
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    J Am Geriatr Soc 57:1403-10. 2009
    ..To estimate the modifying effect of age on the survival benefit associated with adjuvant chemotherapy receipt in elderly patients with a diagnosis of Stage III colon cancer...
  11. doi Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes
    Bruce Stuart
    Pharmaceutical Health Services Research Department, The Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Med Care 50:913-9. 2012
    ..It is not known whether low-income subsidies (LIS) under Medicare Part D help beneficiaries overcome impediments to medication use associated with poor socioeconomic status and high disease burden...
  12. pmc Does medication adherence lower Medicare spending among beneficiaries with diabetes?
    Bruce Stuart
    Epidemiology and Public Health, School of Medicine, University of Maryland Baltimore and Baltimore County, 660 W Redwood St, Baltimore, MD 21201, USA
    Health Serv Res 46:1180-99. 2011
    ....
  13. doi Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease
    Bruce C Stuart
    Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Am J Geriatr Pharmacother 8:441-53. 2010
    ..However, little research has been conducted to compare use versus nonuse of these medications in terms of health-related outcomes in routine practice...
  14. pmc Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes
    Amy Davidoff
    Pharmaceutical Health Services Research, Department School of Pharmacy, University of Maryland Baltimore, Baltimore, MD 21201, USA
    Value Health 15:404-11. 2012
    ..To examine cost responsiveness and total costs associated with a simulated "value-based" insurance design for statin therapy in a Medicare population with diabetes...
  15. pmc Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes
    Sheila Weiss Smith
    Center for Drug Safety, University of Maryland School of Pharmacy, Baltimore, Maryland, 220 Arch Street 12 Floor, Baltimore, Maryland, USA 21201
    Haematologica 97:15-20. 2012
    ..It is not clear whether erythropoiesis stimulating agents are associated with an increased risk of thrombosis in myelodysplastic syndromes, as they are among patients with solid tumors...
  16. pmc Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?
    Bruce Stuart
    Pharmaceutical Health Services Research Department, The Peter Lamy Center for Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Am J Geriatr Pharmacother 8:201-14. 2010
    ..Influenza vaccinations are effective in reducing respiratory infections in younger populations, but it is less certain whether they reduce costs associated with respiratory infections among older adults...
  17. doi Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans
    Bruce Stuart
    Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore, 220 Arch St Baltimore, MD 21230, USA
    Med Care 49:511-5. 2011
    ..The question for policy makers is whether beneficiaries enrolled in Part D plans exhibit drug utilization patterns comparable with those seen in retiree plans...
  18. doi Are there differential effects of managed care on publicly insured children with chronic health conditions?
    Amy Davidoff
    University of Maryland Baltimore
    Med Care Res Rev 65:356-72. 2008
    ....
  19. ncbi Effects of the State Children's Health Insurance Program Expansions on children with chronic health conditions
    Amy Davidoff
    Department of Public Policy, University of Maryland Baltimore County, 21250, USA
    Pediatrics 116:e34-42. 2005
    ..To estimate the effects of the State Children's Health Insurance Program (SCHIP) expansions on insurance coverage, use of health care services, and access to care for children with chronic health conditions...
  20. ncbi The effect of parents' insurance coverage on access to care for low-income children
    Amy Davidoff
    Urban Institute, Washington DC 20037, USA
    Inquiry 40:254-68. 2003
    ..Although the magnitude of these effects is small relative to the direct effect of providing insurance to either the child or parent, they should be considered in analyses of costs and benefits of proposed policies...